Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
NCT ID: NCT06529094
Last Updated: 2025-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
808 participants
INTERVENTIONAL
2024-11-01
2028-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preventing Pressure Ulcers in Veterans With Spinal Cord Injury (SCI)
NCT00105859
Pressure Ulcer Prevention for SCI Using a Tele Home Program
NCT01166828
Enhancing Recovery in Non-Traumatic Spinal Cord Injury
NCT03320759
In-Home Adjustment of New Spinal Cord Injury Caregivers
NCT03244098
CMAP Refinement for Pressure Injury Prevention
NCT04309864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preparation to implement the CAPP-FIT per site
Complete clinic workflow designs and redesigns to integrate CAPP-FIT into clinic workflow per site. Recruit and train providers in use of the CAPP-FIT through TMS training, demonstration, and simulation with a standardized patient.
Provider training
Provider participants will complete TMS training, CAPP-FIT demonstration and simulation in use of the CAPP-FIT with a standardized patient.
Implement CAPP-FIT with RA facilitation
Veteran completes Veteran Survey and Provider uses Provider report around an established clinic visit per site
CAPP-FIT intervention with RA facilitation
After consent and survey completion, RA to email/text CAPP-FIT link to Veteran the day before established clinic visit. RA to remain available to answer questions to help Veteran participant complete Veteran Survey and submit the responses through eScreening. The Provider Report will appear in CPRS with a Provider notification. RA to meet Veteran participant in the clinic after the clinic visit to complete the Veteran satisfaction survey.
Implement CAPP-FIT without RA facilitation
Each site will determine how they will integrate use of the CAPP-FIT in clinic workflow.
CAPP-FIT implementation during maintenance phase
Providers will attend focus group after Arm 2 to determine sustainability of CAPP-FIT use in clinic workflow. Clinic provider will act on that determination for 10 months during maintenance phase.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provider training
Provider participants will complete TMS training, CAPP-FIT demonstration and simulation in use of the CAPP-FIT with a standardized patient.
CAPP-FIT intervention with RA facilitation
After consent and survey completion, RA to email/text CAPP-FIT link to Veteran the day before established clinic visit. RA to remain available to answer questions to help Veteran participant complete Veteran Survey and submit the responses through eScreening. The Provider Report will appear in CPRS with a Provider notification. RA to meet Veteran participant in the clinic after the clinic visit to complete the Veteran satisfaction survey.
CAPP-FIT implementation during maintenance phase
Providers will attend focus group after Arm 2 to determine sustainability of CAPP-FIT use in clinic workflow. Clinic provider will act on that determination for 10 months during maintenance phase.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* assigned provider in SCI clinic who is willing to participate in the study
* has a scheduled appointment in the SCI clinic
* ability to complete survey
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Palo Alto Health Care System
FED
VA Long Beach Healthcare System
FED
Saint Louis VA Medical Center
FED
James A. Haley Veterans' Hospital
UNKNOWN
Louis Stokes VA Medical Center
FED
Michael E. DeBakey VA Medical Center
FED
Iowa City Veterans Affairs Medical Center
FED
San Diego Veterans Healthcare System
FED
Edward Hines Jr. VA Hospital
FED
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth E Burkhart, PhD
Role: PRINCIPAL_INVESTIGATOR
Edward Hines Jr. VA Hospital, Hines, IL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California, United States
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States
James A. Haley Veterans' Hospital, Tampa, FL
Tampa, Florida, United States
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
St Louis, Missouri, United States
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HX003704
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IIR 22-163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.